Alessio Menconi

Florence, 50134, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth.

Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth.

Journal: Cell communication and signaling : CCS

Published: September 04, 2025

The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.

The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.

Journal: Hepatology (Baltimore, Md.)

Published: April 17, 2025

The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: February 20, 2025

Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells.

Liquid Crystalline Networks Hamper the Malignancy of Cancer Cells.

Journal: Advanced healthcare materials

Published: September 20, 2024

ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2.

ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: January 24, 2024

Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.

Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.

Journal: Molecular oncology

Published: October 03, 2023

Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma.

Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma.

Journal: The American journal of pathology

Published: September 15, 2023

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.

Journal: Cells

Published: January 11, 2023

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.

Journal: International journal of molecular sciences

Published: September 10, 2021

Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.

Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.

Journal: Cancer research

Published: April 10, 2021

Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA-PEG nanoparticles.

Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA-PEG nanoparticles.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: October 10, 2020

Correction to: Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.

Correction to: Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: November 21, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026